Insights
Insights From Our Experts
Articles
The State of National Healthcare Policy and Pricing Webinar 2023
2023 is shaping up to be an interesting year for Pharma/Biotech companies and their commercial and government pricing strategies and contracts. There are multiple policies and rules being discussed, already proposed, under review, in litigation, and…
Optimizing and Accelerating Membership Management Within the Healthcare Industry
The various complexities and ever-changing nature of the pharmaceutical and health care industries create endless intricate processes, datasets and other components for manufacturers to navigate. Properly maintaining a Customer Master can be one of the most…
Ask the Attorneys: What Keeps Them Up at Night
EVERSANA’s Mike Kurland, Vice President, Revenue Management and Compliance, joined a panel of industry experts to present, “Ask the Attorneys: What Keeps Them Up at Night?” at Informa Connect’s Medical Drug Rebate Program Summit. Session Summary…
Brand Planning – Fitting Financial and Copay Services into Existing Models
EVERSANA’s Kevin O’Meara, Vice President, Patient Services Solutions, and Chris Lagoerio, Director, Revenue Management, presented a session, “Brand Planning – Fitting Financial and Copay Services into Existing Models,” at Informa Connect’s Copay, Reimbursement and Access Congress.…
Operational Concerns for Key Enacted and Proposed Changes Under Medicare and Medicaid
EVERSANA’s Mike Kurland, Vice President, Revenue Management & Compliance, delivered a presentation on Operational Concerns for Key Enacted and Proposed Changes Under Medicare and Medicaid at Informa Connect’s Medicaid & Government Pricing Congress. Mike discussed the…
Aligning Net Pricing with Patient Outcomes – Removing Barriers to Value-Based Contracting
While value-based contracting has long been heralded as a way to ensure the cost of life-changing and life-saving medicines are aligned with patient outcomes, the complexity in their implementation has limited adoption to just a few…
BLOG: Segmenting Health Systems
Posted by
Dr. Richard Stefanacci on December 1, 202112/1/21
The COVID-19 pandemic has separated health systems based on the impact of the pandemic on their staff, operations and finances. While many health systems have struggled in these areas, some have truly succeeded. This means that…
BLOG: Moving to More Comprehensive HEOR Data
Posted by
Dr. Richard Stefanacci on September 28, 20219/28/21
Health economics and outcomes research (HEOR) by definition is a discipline that is used to complement traditional clinical development information (i.e., efficacy, safety, quality) to guide patient access decision-makers to specific drugs and services. The foundation of…
BLOG: Targeting the ‘Right’ Patient — How Pharmaceutical Companies Can Help Physicians Connect Patients to the Right Treatments
Posted by
Dr. Richard Stefanacci on September 10, 20219/10/21
Not every drug is right for every patient, but for some — or the “right” patient — treatment can provide significant clinical and financial benefits. For new therapies, identification of the right patient can be a…
BLOG: Medication Adherence Opportunities and Challenges
Posted by
Dr. Richard Stefanacci on August 20, 20218/20/21
“Drugs don’t work in patients who don’t take them.” − Former U.S. Surgeon General C. Everett Coop While it seems obvious, the amount of attention given to adherence is extremely low, especially in comparison to the high costs associated with non-adherence.…